Comparing biologic persistence and healthcare costs in rheumatoid arthritis patients initiating subcutaneous biologics. [electronic resource]
Producer: 20190603Description: 659-669 p. digitalISSN:- 2042-6313
- Abatacept -- administration & dosage
- Adalimumab -- administration & dosage
- Administration, Cutaneous
- Adolescent
- Adult
- Aged
- Antirheumatic Agents -- administration & dosage
- Arthritis, Rheumatoid -- drug therapy
- Biological Factors -- administration & dosage
- Biological Products -- administration & dosage
- Cohort Studies
- Etanercept -- administration & dosage
- Female
- Health Care Costs
- Humans
- Male
- Middle Aged
- Retrospective Studies
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article; Observational Study
There are no comments on this title.
Log in to your account to post a comment.